Milestones Abound In First Quarter The first quarter was a busy three months for Kamada as it hit several milestones, including the launch of a new post-marketing research program aimed at generating ...

Cytogam® is contraindicated in individuals with a history of a prior severe reaction associated with the administration of this or other human immunoglobulin preparations.

DETROIT, MICHIGAN - June 6, 2025 (NEWMEDIAWIRE) - Cytomegalovirus (CMV) is a common virus that most adults are exposed to at some point in their lives, and over half of American adults have been ...

In 2021, Kamada acquired CYTOGAM from its previous owner, and in 2023 the company received approval from the U.S. Food and Drug Administration for the manufacturing of the product.

Cytogam's sales were similar to Q1 2024, as we had a strong quarter back then due to fresh inventory. The expanded studies aim to present new clinical data, which started in 2023, to potentially ...

Start Time: 08:30 January 1, 0000 8:53 AM ET. Kamada Ltd. (NASDAQ:KMDA)Q1 2025 Earnings Conference Call May 14, 2025, 08:30 AM ET. Company Participants. Amir London - CEO ...

Launched Comprehensive Post-Marketing Research Program of CYTOGAM® Reiterating Full Year 2025 Guidance, Representing Double Digit Profitable Growth Year-over-Year ; ...

Revenues for First Quarter of 2025 of $44.0 Million, Representing a 17% Year-over-Year Increase; First Quarter Adjusted EBITDA of $11.6 Million, Up 54% Year-over-Year; Strong Financial Position to ...

Program Aimed at Generating Key Data in Support of the Benefits of CYTOGAM® in the Management of Cytomegalovirus (CMV) in Solid Organ Transplantation A Total of 10 Studies will be Conducted in ...

Program Aimed at Generating Key Data in Support of the Benefits of CYTOGAM® in the Management of Cytomegalovirus (CMV) in Solid Organ TransplantationA Total of 10 Studies will be Conducted in ...

CYTOGAM® (Cytomegalovirus Immune Globulin Intravenous [Human]) (CMV-IGIV) is indicated for the prophylaxis of cytomegalovirus disease associated with the transplantation of the kidney, ...